Weekly Digest – August 2024 Weekly Digest – August 2024 13 Aug 2024: Enhertu approved in China for patients with previously treated HER2-positive advanced or metastatic gastric cancer AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has received conditional approval in […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id